Page 5 of articles about vaccine in Press releases

Veterinarians and farmers across the globe have reached the landmark of protecting one billion pigs from the potentially devastating effects of Porcine Circovirus Disease (PCVD) using Ingelvac CircoFLEX®

Ecoporc Shiga induces a high level of immunity against shigatoxin, produced by E coli bacteria which cause edema.

As flu season swings into full gear, producers and those who work with pigs are reminded that it’s not too late to get a seasonal flu vaccination.

The U.S. Department of Homeland Security has awarded Harrisvaccines a $1 million-plus contract to develop a vaccine for foot-and-mouth disease, one of the world’s most economically devastating animal diseases.

A vaccine program can help prevent many potential problems for producers. However, if vaccines aren't stored and handled correctly, the program can be ineffective.

Virbac has entered into a new strategic alliance in food-producing animals vaccines, by setting up a joint-venture with the Taiwanese company Schweitzer Biotech Company (SBC).

Mycoplasmal pneumonia and porcine circovirus are two of the costliest diseases affecting pork producers. Helping provide protection before disease exposure is critical to the success of any vaccination program.

Merck Animal Health (known as MSD Animal Health outside the USA and Canada) today announced that it has received marketing authorization in the European Union for PORCILIS® M Hyo ID ONCE, the first single-shot vaccine against Mycoplasma hyopneumoniae (M Hyo) infection in pigs for intradermal administration.

Inovio Pharmaceuticals, Inc., a leader in the development of synthetic immunogens against cancers and infectious diseases, announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with the United States Department of Homeland Security (DHS) Science and Technology Directorate Plum Island Animal Disease Center. This collaboration will evaluate the efficacy of Inovio's SynCon® vaccines for foot & mouth disease (FMD) in important animal models including cattle, sheep, and pigs.

Canadian swine producers can now vaccinate for mycoplasma pneumonia when they process baby pigs. A new label claim makes RespiSure-ONE the only vaccine approved for administration at one day of age.

Nearly every pig in Canada receives a vaccine for protection against porcine circovirus (PCV), and now swine producers have a new option for efficacious protection with the registration of Fostera PCV from Pfizer Animal Health.

Merck Animal Health (MSD Animal Health outside the USA and Canada), formerly known as Intervet/Schering-Plough Animal Health, has opened today an expansion of a vaccine manufacturing unit at its Elkhorn Biotechnology Excellence Center.

South Dakota State University is partnering with animal health leader Boehringer Ingelheim Vetmedica, Inc. to develop a new technology to protect pigs against a deadly form of E. coli.

Merck Animal Health, formerly known as Intervet/Schering-Plough Animal Health, announced today that it has embarked on the expansion of a vaccine manufacturing unit at its Biosciences Center Boxmeer campus in the Netherlands.

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced that its Chief Veterinary Scientific Officer, Dr. Dragan Rogan, was an invited speaker at the 56th International Meat Industry Conference being held in Tara, Serbia.

Intervet/Schering-Plough Animal Health announces today that it is introducing PORCILIS® AR-T DF, an inactivated vaccine against progressive atrophic rhinitis in piglets with a new adjuvant associated with fewer injection site reactions.